Answers are grounded in this paper and cite their sources.
Background Clinical practice guidelines recommend a variety of investigations to identify potential causes of second trimester pregnancy loss (STPL), stillbirth (SB) and neonatal death (NND); however, there is a paucity of data regarding their uptake and the results obtained. We aimed to determine the frequency of use of investigations and their positive yield following STPL, SB and NND. Methods A single centre review of all STPL, SB and NND (excluding termination of pregnancy) between January and December 2024 at a UK tertiary maternity centre was undertaken (n = 121). The investigations performed, and whether their result was abnormal were recorded, together with information about the type of perinatal loss. Results 72 STPL, 40 SB, and 9 NND cases were included. Placental histopathology found abnormalities evident in 83/105 cases (79.0%). Fetal cytogenetics were abnormal in 2/32 cases (6.3%). Post-mortem demonstrated abnormal findings in 10/16 cases (62.5%). Infection screening was positive in 24/65 placental swabs (36.9%), 8/31 axilla swabs (25.8%) and 4/24 blood cultures (16.7%). Haematological screening yielded abnormal results in 6/78 bile acids (7.7%), 7/75 urate (9.3%) and 23/80 thyroid screens (28.8%). HbA1c, anti-cardiolipin and anti-β2-glycoprotein antibodies were normal. Conclusions The frequency with which investigations were performed varied; in some cases, this was due to the clinical context. Placental histopathology, post-mortem, microbiology swabs and thrombophilia screen were more frequently abnormal, though their clinical significance remains unclear. Large-scale studies involving multiple centres, and stratification of patient phenotype, are needed to determine which investigations are most useful after late miscarriage and perinatal death
No takes yet. Share an insight, caveat, or question.
Bowes et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: